LEADER 03904nam 22006135 450 001 9910254516103321 005 20200706032350.0 010 $a81-322-2295-4 024 7 $a10.1007/978-81-322-2295-8 035 $a(CKB)3710000000515955 035 $a(EBL)4092978 035 $a(SSID)ssj0001585637 035 $a(PQKBManifestationID)16264608 035 $a(PQKBTitleCode)TC0001585637 035 $a(PQKBWorkID)14864423 035 $a(PQKB)11325715 035 $a(DE-He213)978-81-322-2295-8 035 $a(MiAaPQ)EBC4092978 035 $a(PPN)190515317 035 $a(EXLCZ)993710000000515955 100 $a20151113d2016 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aUveitis: An Update$b[electronic resource] /$fedited by Jyotirmay Biswas, Parthopratim Dutta Majumder 205 $a1st ed. 2016. 210 1$aNew Delhi :$cSpringer India :$cImprint: Springer,$d2016. 215 $a1 online resource (180 p.) 300 $aDescription based upon print version of record. 311 $a81-322-2294-6 320 $aIncludes bibliographical references at the end of each chapters. 327 $aChapter 1 Advances in ocular toxoplasmosis -- Chapter 2 Viral anterior uveitis -- Chapter 3 Behçet disease -- Chapter 4 Biologicals in uveitis -- Chapter 5 Corticosteroid in uveitis -- Chapter 6 Glaucoma in uveitis -- Chapter 7 Ocular lesions in AIDS -- Chapter 8 imaging in uveitis -- Chapter 9 Immunosuppressives inuveitis and ocular inflammation -- Chapter 10 Intraocular lymphoma -- Chapter11 Intermediate uveitis -- Chapter 12 Management of inflammatory CNV.-Chapter 13 Ocular parasitic infections -- Chapter 14 Ocular sarcoidosis -- Chapter 15 Intraocular tuberculosis -- Chapter 16 Paediatric uveitis -- Chapter 17 Serpiginous choroiditis -- Chapter 18 White dot syndromes. 330 $aThis book on recent advances in uveitis provides readers with up-to-date and clinically-relevant information on 18 topics that are indispensable for everyday practice. This book is meant for bridging the gap between recent developments and their incorporation into clinical use. Written by global experts, the topics cover advances in diagnosis and treatment of distinct clinical varieties of uveitis. Additionally, the chapter on imaging describes the various imaging modalities that aid clinching the diagnosis with greater accuracy. Role of corticosteroids, their mechanism of action and various routes of drug delivery too have been discussed in detail. Optimal use of various immunomodulators, their role, dose, mechanism of action, side effects, and monitoring during patient follow-up have been elucidated in easy-to-understand tables. There are two chapters on complications in uveitis, one on glaucoma and other on choroidal neovascularization. A chapter on pediatric uveitis highlights the challenges and provides guidance to manage this special population. 606 $aOphthalmology 606 $aMedicine 606 $aInternal medicine 606 $aOphthalmology$3https://scigraph.springernature.com/ontologies/product-market-codes/H44004 606 $aMedicine/Public Health, general$3https://scigraph.springernature.com/ontologies/product-market-codes/H00007 606 $aInternal Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H33002 615 0$aOphthalmology. 615 0$aMedicine. 615 0$aInternal medicine. 615 14$aOphthalmology. 615 24$aMedicine/Public Health, general. 615 24$aInternal Medicine. 676 $a610 702 $aBiswas$b Jyotirmay$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aMajumder$b Parthopratim Dutta$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910254516103321 996 $aUveitis: An Update$92523125 997 $aUNINA